US 8859506
Glycopeptide phosphonate derivatives
granted A61KA61K38/14A61K47/06
Quick answer
US patent 8859506 (Glycopeptide phosphonate derivatives) held by THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
- Grant date
- Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/14, A61K47/06, A61K47/12, A61K47/26